全文获取类型
收费全文 | 2269篇 |
免费 | 159篇 |
专业分类
2428篇 |
出版年
2021年 | 14篇 |
2019年 | 19篇 |
2018年 | 20篇 |
2017年 | 15篇 |
2016年 | 24篇 |
2015年 | 46篇 |
2014年 | 46篇 |
2013年 | 82篇 |
2012年 | 113篇 |
2011年 | 109篇 |
2010年 | 57篇 |
2009年 | 65篇 |
2008年 | 92篇 |
2007年 | 103篇 |
2006年 | 102篇 |
2005年 | 111篇 |
2004年 | 97篇 |
2003年 | 107篇 |
2002年 | 77篇 |
2001年 | 22篇 |
2000年 | 30篇 |
1999年 | 30篇 |
1998年 | 39篇 |
1997年 | 29篇 |
1996年 | 30篇 |
1995年 | 24篇 |
1994年 | 28篇 |
1993年 | 21篇 |
1992年 | 35篇 |
1991年 | 32篇 |
1990年 | 31篇 |
1989年 | 28篇 |
1988年 | 20篇 |
1987年 | 34篇 |
1986年 | 30篇 |
1985年 | 33篇 |
1984年 | 32篇 |
1983年 | 36篇 |
1982年 | 27篇 |
1981年 | 23篇 |
1980年 | 15篇 |
1979年 | 18篇 |
1978年 | 15篇 |
1977年 | 19篇 |
1976年 | 17篇 |
1975年 | 15篇 |
1973年 | 21篇 |
1972年 | 14篇 |
1969年 | 21篇 |
1964年 | 16篇 |
排序方式: 共有2428条查询结果,搜索用时 0 毫秒
91.
92.
93.
94.
95.
96.
Extraction of 14 teeth in six patients taking dicumarol caused no unusual bleeding. Discontinuance of dicumarol prior to dental extraction should not necessarily be a routine procedure; in certain persons with a demonstrated strong tendency to recurrent thrombosis, dicumarol should be continued, based on the decision that the danger of clotting without the drug is greater than the danger of bleeding with the drug. 相似文献
97.
98.
Clifford Allen 《BMJ (Clinical research ed.)》1946,1(4440):217-218
99.
Cardiovascular disease (CVD) risk in India is currently assessed using the World Health Organization/International Society for Hypertension (WHO/ISH) risk prediction charts since no population-specific models exist. The WHO/ISH risk prediction charts have two versions—one with total cholesterol as a predictor (the high information (HI) model) and the other without (the low information (LI) model). However, information on the WHO/ISH risk prediction charts including guidance on which version to use and when, as well as relative performance of the LI and HI models, is limited. This article aims to, firstly, quantify the relative performance of the LI and HI WHO/ISH risk prediction (for WHO-South East Asian Region D) using data from rural India. Secondly, we propose a pre-screening (simplified) point-of-care (POC) test to identify patients who are likely to benefit from a total cholesterol (TC) test, and subsequently when the LI model is preferential to HI model. Analysis was performed using cross-sectional data from rural Andhra Pradesh collected in 2005 with recorded blood cholesterol measurements (N = 1066). CVD risk was computed using both LI and HI models, and high risk individuals who needed treatment(T
HR) were subsequently identified based on clinical guidelines. Model development for the POC assessment of a TC test was performed through three machine learning techniques: Support Vector Machine (SVM), Regularised Logistic Regression (RLR), and Random Forests (RF) along with a feature selection process. Disagreement in CVD risk predicted by LI and HI WHO/ISH models was 14.5% (n = 155; p<0.01) overall and comprised 36 clinically relevant T
HR patients (31% of patients identified as T
HR by using either model). Using two patient-specific parameters (age, systolic blood pressure), our POC assessment can pre-determine the benefit of TC testing and choose the appropriate risk model (out-of-sample AUCs:RF-0.85,SVM-0.84,RLR:0.82 and maximum sensitivity-98%). The identification of patients benefitting from a TC test for CVD risk stratification can aid planning for resource-allocation and save costs for large-scale screening programmes. 相似文献
100.
The TEL-Syk fusion protein was isolated from a patient with myelodysplasia with megakaryocyte blasts. Expression of TEL-Syk transforms interleukin-3 (IL-3)-dependent Ba/F3 cells in vitro by deregulating STAT5-mediated signal transduction pathways. In vivo, TEL-Syk expression in pre-B cells blocks B cell differentiation, leading to lymphoid leukemia. Here, we demonstrate that TEL-Syk introduced into fetal liver hematopoietic cells, which are then adoptively transferred into lethally irradiated recipients, leads to an aggressive myelodysplasia with myelofibrosis that is lethal in mice by 60–75 days. Expression of TEL-Syk induces a short-lived myeloexpansion that is rapidly followed by bone marrow failure and extreme splenic/hepatic fibrosis accompanied by extensive apoptosis. The disease is dependent on Syk kinase activity. Analysis of serum from TEL-Syk mice reveals an inflammatory cytokine signature reminiscent of that found in the sera from patients and mouse models of myeloproliferative neoplasms. TEL-Syk expressing cells showed constitutive STAT5 phosphorylation, which was resistant to JAK inhibition, consistent with deregulated cytokine signaling. These data indicate that expression of TEL-Syk in fetal liver hematopoietic cells results in JAK-independent STAT5 phosphorylation ultimately leading to a uniquely aggressive and lethal form of myelofibrosis. 相似文献